Male breast cancer (MBC) is a rare disease whose etiology appears to be largely associated with genetic factors.BRCA1andBRCA2mutations account for about 10% of all MBC cases. Thus, a fraction of MBC cases are expected to be due to genet-ic factors not yet identified. To further explain the genetic susceptibility for MBC, whole-exome sequencing (WES) and targeted genesequencing were applied to high-risk,BRCA1/2mutation–negative MBC cases.METHODS:Germ-line DNA of 1 male and 2 femaleBRCA1/2mutation–negative breast cancer (BC) cases from a pedigree showing a first-degree family history of MBC was analyzedwith WES. Targeted gene sequencing for the validation of WES results was performed for 48 high-risk,BRCA1/2mutation–negativeMBC cases from an Italian multicenter study of MBC. A case-control series of 433BRCA1/2mutation–negative MBC and female breastcancer (FBC) cases and 849 male and female controls was included in the study.RESULTS:WES in the family identified the partnerand localizer of BRCA2 (PALB2) c.419delA truncating mutation carried by the proband, her father, and her paternal uncle (all affectedwith BC) and theN-acetyltransferase 1 (NAT1) c.97C>T nonsense mutation carried by the proband’s maternal aunt. TargetedPALB2sequencing detected the c.1984A>T nonsense mutation in 1 of the 48BRCA1/2mutation–negative MBC cases.NAT1c.97C>T was notfound in the case-control series.CONCLUSIONS:These results add strength to the evidence showing thatPALB2is involved in BCrisk for both sexes and indicate that consideration should be given to clinical testing ofPALB2forBRCA1/2mutation–negative fami-lies with multiple MBC and FBC cases.Cancer2016;000:000–000.VC2016 American Cancer Society.KEYWORDS:genetic susceptibility, male breast cancer,N-acetyltransferase 1 (NAT1), partner and localizer of BRCA2 (PALB2), whole-exome sequencing.

Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene / Silvestri, Valentina; Zelli, Veronica; Valentini, Virginia; Rizzolo, Piera; Navazio, Anna Sara; Coppa, Anna; Agata, Simona; Oliani, Cristina; Barana, Daniela; Castrignanò, Tiziana; Viel, Alessandra; Russo, Antonio; Tibiletti, Maria Grazia; Zanna, Ines; Masala, Giovanna; Cortesi, Laura; Manoukian, Siranoush; Azzollini, Jacopo; Peissel, Bernard; Bonanni, Bernardo; Peterlongo, Paolo; Radice, Paolo; Palli, Domenico; Giannini, Giuseppe; Chillemi, Giovanni; Montagna, Marco; Ottini, Laura. - (2016). [10.1002/cncr.30337]

Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene

SILVESTRI, VALENTINA;zelli, veronica;VALENTINI, VIRGINIA;RIZZOLO, PIERA;Navazio, Anna Sara;COPPA, Anna;GIANNINI, Giuseppe;OTTINI, LAURA
2016

Abstract

Male breast cancer (MBC) is a rare disease whose etiology appears to be largely associated with genetic factors.BRCA1andBRCA2mutations account for about 10% of all MBC cases. Thus, a fraction of MBC cases are expected to be due to genet-ic factors not yet identified. To further explain the genetic susceptibility for MBC, whole-exome sequencing (WES) and targeted genesequencing were applied to high-risk,BRCA1/2mutation–negative MBC cases.METHODS:Germ-line DNA of 1 male and 2 femaleBRCA1/2mutation–negative breast cancer (BC) cases from a pedigree showing a first-degree family history of MBC was analyzedwith WES. Targeted gene sequencing for the validation of WES results was performed for 48 high-risk,BRCA1/2mutation–negativeMBC cases from an Italian multicenter study of MBC. A case-control series of 433BRCA1/2mutation–negative MBC and female breastcancer (FBC) cases and 849 male and female controls was included in the study.RESULTS:WES in the family identified the partnerand localizer of BRCA2 (PALB2) c.419delA truncating mutation carried by the proband, her father, and her paternal uncle (all affectedwith BC) and theN-acetyltransferase 1 (NAT1) c.97C>T nonsense mutation carried by the proband’s maternal aunt. TargetedPALB2sequencing detected the c.1984A>T nonsense mutation in 1 of the 48BRCA1/2mutation–negative MBC cases.NAT1c.97C>T was notfound in the case-control series.CONCLUSIONS:These results add strength to the evidence showing thatPALB2is involved in BCrisk for both sexes and indicate that consideration should be given to clinical testing ofPALB2forBRCA1/2mutation–negative fami-lies with multiple MBC and FBC cases.Cancer2016;000:000–000.VC2016 American Cancer Society.KEYWORDS:genetic susceptibility, male breast cancer,N-acetyltransferase 1 (NAT1), partner and localizer of BRCA2 (PALB2), whole-exome sequencing.
2016
Genetic susceptibility; Male breast cancer; N-acetyltransferase 1 (NAT1); Partner and localizer of BRCA2 (PALB2); Whole-exome sequencing; Oncology; Cancer Research
01 Pubblicazione su rivista::01a Articolo in rivista
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene / Silvestri, Valentina; Zelli, Veronica; Valentini, Virginia; Rizzolo, Piera; Navazio, Anna Sara; Coppa, Anna; Agata, Simona; Oliani, Cristina; Barana, Daniela; Castrignanò, Tiziana; Viel, Alessandra; Russo, Antonio; Tibiletti, Maria Grazia; Zanna, Ines; Masala, Giovanna; Cortesi, Laura; Manoukian, Siranoush; Azzollini, Jacopo; Peissel, Bernard; Bonanni, Bernardo; Peterlongo, Paolo; Radice, Paolo; Palli, Domenico; Giannini, Giuseppe; Chillemi, Giovanni; Montagna, Marco; Ottini, Laura. - (2016). [10.1002/cncr.30337]
File allegati a questo prodotto
File Dimensione Formato  
Silvestri_Whole-Exome_2016.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 327.02 kB
Formato Adobe PDF
327.02 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/905358
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 26
social impact